Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 5;21(12):66.
doi: 10.1007/s11926-019-0865-2.

Erdheim-Chester Disease: a Concise Review

Matthias Papo  1   2 , Jean-François Emile  3 , Thiago Trovati Maciel  2 , Pierre Bay  1 , Alistair Baber  1 , Olivier Hermine  2 , Zahir Amoura  1 , Julien Haroche  4
Affiliations
Review

Erdheim-Chester Disease: a Concise Review

Matthias Papo et al. Curr Rheumatol Rep. .

Abstract

Purpose of review: This report provides an overview of the current knowledge of molecular characterization, clinical description, and treatment of Erdheim-Chester disease (ECD), a multi-systemic adult histiocytosis of the L group.

Recent findings: The recent identification of several MAPK mutations in histiocytes of ECD lesions. Leading to targeted therapies. The discovery of the BRAFV600E mutation in ECD lesions followed by several other kinase mutations in the MAPK pathway has revolutionized our understanding of the disease pathogenesis and led to trials with targeted therapies that demonstrated robust efficacy.

Keywords: Erdheim-Chester Disease; Histiocytic Neoplasm; Histiocytosis; Myeloid Neoplasm; Targeted Therapy.

PubMed Disclaimer

References

    1. Nat Med. 2019 Dec;25(12):1839-1842 - PubMed
    1. Blood. 2014 Aug 14;124(7):1119-26 - PubMed
    1. Oncoimmunology. 2018 Mar 15;7(7):e1440929 - PubMed
    1. Haematologica. 2019 Mar;104(3):e97-e99 - PubMed
    1. Blood. 2014 Nov 6;124(19):3016-9 - PubMed

MeSH terms

LinkOut - more resources